Prevalence of fibrosis and steatosis determined by transient elastography and controlled attenuation parameter (Fibroscan®) in diabetic patients

Introduction and Objectives: Globally, a higher prevalence of metabolic dysfunction-associated fatty liver disease (MAFLD) has been reported in diabetics (55.5%) compared to the general population (25%). In Mexico, there is a lack of studies on diabetes (DM2) in this subgroup. Objective: To determin...

Full description

Saved in:
Bibliographic Details
Main Authors: Kevin S. Vázquez-Hernández, Andres Burak-Leipuner, Alfredo I. Servin-Caamaño, Javier A. Romero-Bermúdez, Laura E. Ceceña-Martínez, José L. Pérez-Hernández, María C. Castañeda-Aguilar, Fátima Higuera-de la Tijera
Format: Article
Language:English
Published: Elsevier 2025-04-01
Series:Annals of Hepatology
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268125000390
Tags: Add Tag
No Tags, Be the first to tag this record!